a. Reducing Radioiodine Treatment in Papillary Thyroid Cancer. RAILESS
Condition(s):to Omit Radioiodine Treatment Safely in Patients With Low -Risk Papillary Thyroid Cancer With Seize of 11-20mmLast Updated:February 21, 2024Active, not recruiting
Hide Studies Not Open or Pending
Condition(s):to Omit Radioiodine Treatment Safely in Patients With Low -Risk Papillary Thyroid Cancer With Seize of 11-20mmLast Updated:February 21, 2024Active, not recruiting
Condition(s):Papillary Thyroid CancerLast Updated:May 24, 2023Completed
Condition(s):Papillary Thyroid CancerLast Updated:March 6, 2023Recruiting
Condition(s):Thyroid Cancer; Papillary Thyroid CarcinomaLast Updated:February 26, 2024Not yet recruiting
Condition(s):Thyroid CancerLast Updated:December 6, 2017Completed
Condition(s):Papillary Thyroid CancerLast Updated:July 14, 2020Unknown status
Condition(s):Papillary Thyroid CancerLast Updated:January 13, 2012Completed
Condition(s):Positron-Emission Tomography; Lymph Node Metastases; Thyroid CancerLast Updated:July 28, 2022Recruiting
Condition(s):Papillary Thyroid Cancer; Papillary Thyroid Carcinoma; Papillary Microcarcinoma of the ThyroidLast Updated:February 8, 2021Recruiting
Condition(s):Papillary Thyroid CancerLast Updated:June 12, 2017Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.